A citation-based method for searching scientific literature

Jo-Ann Johnson, Kim MacDonald, Gwen Clarke, Amanda Skoll. J Obstet Gynaecol Can 2017
Times Cited: 14







List of co-cited articles
175 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Presence of fetal DNA in maternal plasma and serum.
Y M Lo, N Corbetta, P F Chamberlain, V Rai, I L Sargent, C W Redman, J S Wainscoat. Lancet 1997
42

Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark.
F Banch Clausen, R Steffensen, M Christiansen, M Rudby, M A Jakobsen, T R Jakobsen, G R Krog, R D Madsen, K R Nielsen, K Rieneck,[...]. Prenat Diagn 2014
55
42

Costs and benefits of non-invasive fetal RhD determination.
L Teitelbaum, A Metcalfe, G Clarke, J S Parboosingh, R D Wilson, J M Johnson. Ultrasound Obstet Gynecol 2015
30
42


Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands.
Masja de Haas, Florentine F Thurik, Catharina P B van der Ploeg, Barbera Veldhuisen, Hoang Hirschberg, Aicha Ait Soussan, Heleen Woortmeijer, Frithjofna Abbink, Godelieve C M L Page-Christiaens, Peter G Scheffer,[...]. BMJ 2016
52
35


Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland.
Katri Haimila, Kati Sulin, Malla Kuosmanen, Inna Sareneva, Anu Korhonen, Suvi Natunen, Jarno Tuimala, Susanna Sainio. Acta Obstet Gynecol Scand 2017
29
35

Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy.
Agneta Taune Wikman, Eleonor Tiblad, Anita Karlsson, Martin L Olsson, Magnus Westgren, Marie Reilly. Obstet Gynecol 2012
64
35

Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis.
Angela F Hawk, Eugene Y Chang, Sally M Shields, Kit N Simpson. Obstet Gynecol 2013
30
35



Cost-effectiveness of the management of rh-negative pregnant women.
Julie Duplantie, Odilon Martinez Gonzales, Antoine Bois, Léon Nshimyumukiza, Jean Gekas, Emmanuel Bujold, Valérie Morin, Maud Vallée, Yves Giguère, Christian Gagné,[...]. J Obstet Gynaecol Can 2013
15
35


Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study.
Lyn S Chitty, Kirstin Finning, Angela Wade, Peter Soothill, Bill Martin, Kerry Oxenford, Geoff Daniels, Edwin Massey. BMJ 2014
64
28


Routine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and quality.
Rebecca M Turner, Myfanwy Lloyd-Jones, Dilly O C Anumba, Gordon C S Smith, David J Spiegelhalter, Hazel Squires, John W Stevens, Michael J Sweeting, Stanislaw J Urbaniak, Robert Webster,[...]. PLoS One 2012
37
28

Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program.
Eleonor Tiblad, Agneta Taune Wikman, Gunilla Ajne, Agneta Blanck, Yvonne Jansson, Anita Karlsson, Elisabeth Nordlander, Bibi Shassti Holländer, Magnus Westgren. PLoS One 2013
33
28


Noninvasive fetal RhD genotyping.
Frederik Banch Clausen, Merete Berthu Damkjær, Morten Hanefeld Dziegiel. Transfus Apher Sci 2014
26
28

Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis.
Louisa G Gordon, Catherine A Hyland, Jonathan A Hyett, Helen O'Brien, Glenda Millard, Robert L Flower, Glenn J Gardener. Prenat Diagn 2017
11
36

Rh isoimmunization during pregnancy: antenatal prophylaxis.
J M Bowman, B Chown, M Lewis, J M Pollock. Can Med Assoc J 1978
143
28

The scientific basis of antenatal prophylaxis.
S J Urbaniak. Br J Obstet Gynaecol 1998
76
28

No. 197a-Fetal Health Surveillance: Antepartum Consensus Guideline.
Robert Liston, Diane Sawchuck, David Young. J Obstet Gynaecol Can 2018
13
30

No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes.
Francois Audibert, Isabelle De Bie, Jo-Ann Johnson, Nanette Okun, R Douglas Wilson, Christine Armour, David Chitayat, Raymond Kim. J Obstet Gynaecol Can 2017
56
28

High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysis.
Huiqin Yang, Alexis Llewellyn, Ruth Walker, Melissa Harden, Pedro Saramago, Susan Griffin, Mark Simmonds. BMC Med 2019
18
28



Impact of non-invasive fetal RhD genotyping on management costs of rhesus-D negative patients: results of a French pilot study.
Alexandra Benachi, Sophie Delahaye, Nadia Leticee, Jean-Marie Jouannic, Yves Ville, Jean-Marc Costa. Eur J Obstet Gynecol Reprod Biol 2012
21
21

Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy.
Alexandre Vivanti, Alexandra Benachi, François-Xavier Huchet, Yves Ville, Henri Cohen, Jean-Marc Costa. Am J Obstet Gynecol 2016
16
21

Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008.
Tobias Jörg Legler, Sina Patricia Müller, Alexander Haverkamp, Simon Grill, Sinuhe Hahn. Transfus Med Hemother 2009
33
21

Circulating Cell-Free DNA to Determine the Fetal RHD Status in All Three Trimesters of Pregnancy.
Kenneth J Moise, Manisha Gandhi, Noemi H Boring, Richard O'Shaughnessy, Lynn L Simpson, Honor M Wolfe, Jason K Baxter, William Polzin, Keith A Eddleman, Sonia S Hassan,[...]. Obstet Gynecol 2016
12
25


Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days.
Sina P Müller, Iris Bartels, Werner Stein, Günter Emons, Kai Gutensohn, Tobias J Legler. Prenat Diagn 2011
31
21

Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD.
Frederik Banch Clausen, Tanja Roien Jakobsen, Klaus Rieneck, Grethe Risum Krog, Leif Kofoed Nielsen, Ann Tabor, Morten Hanefeld Dziegiel. PLoS One 2013
30
21

The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
Sina P Müller, Iris Bartels, Werner Stein, Günther Emons, Kai Gutensohn, Michael Köhler, Tobias J Legler. Transfusion 2008
82
21

Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis.
Yu-juan Zhu, Ying-ru Zheng, Li Li, Hao Zhou, Xi Liao, Jian-xin Guo, Ping Yi. J Matern Fetal Neonatal Med 2014
19
21

Consequences for fetus and neonate of maternal red cell allo-immunisation.
H Howard, V Martlew, I McFadyen, C Clarke, J Duguid, I Bromilow, J Eggington. Arch Dis Child Fetal Neonatal Ed 1998
47
21

Anti-D in Rh(D)-negative pregnant women: are at-risk pregnancies and deliveries receiving appropriate prophylaxis?
Lawrence Koby, Ami Grunbaum, Alice Benjamin, Robert Koby, Haim A Abenhaim. J Obstet Gynaecol Can 2012
15
21

The pathogenesis and prevention of Rh immunization.
A Zipursky, L G Israels. Can Med Assoc J 1967
132
21

Doppler ultrasonography versus amniocentesis to predict fetal anemia.
Dick Oepkes, P Gareth Seaward, Frank P H A Vandenbussche, Rory Windrim, John Kingdom, Joseph Beyene, Humphrey H H Kanhai, Arne Ohlsson, Greg Ryan. N Engl J Med 2006
125
21

Use of intravenous immunoglobulin in neonates at a tertiary academic hospital: a retrospective 11-year study.
Lani Lieberman, Jordan Spradbrow, Amy Keir, Michael Dunn, Yulia Lin, Jeannie Callum. Transfusion 2016
8
37

The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
Jim Chilcott, Paul Tappenden, Myfanwy Lloyd Jones, Jeremy Wight, Katie Forman, Julie Wray, Catherine Beverley. BJOG 2004
20
21


Cell free fetal DNA to triage antenatal rhesus immune globulin: Is it really cost-effective in the United States?
Kenneth J Moise, Syed Shahrukh Hashmi, Kara Markham, Pedro S Argoti, Michael Bebbington. Prenat Diagn 2019
4
75

A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative.
J Chilcott, M Lloyd Jones, J Wight, K Forman, J Wray, C Beverley, P Tappenden. Health Technol Assess 2003
40
21

High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation.
Pedro Saramago, Huiqin Yang, Alexis Llewellyn, Ruth Walker, Melissa Harden, Stephen Palmer, Susan Griffin, Mark Simmonds. Health Technol Assess 2018
14
21


Should cell-free DNA testing be used to target antenatal rhesus immune globulin administration?
Kimberly K Ma, Maria I Rodriguez, Yvonne W Cheng, Mary E Norton, Aaron B Caughey. J Matern Fetal Neonatal Med 2016
4
50


Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women.
Tamara C Stegmann, Barbera Veldhuisen, Renate Bijman, Florentine F Thurik, Bernadette Bossers, Goedele Cheroutre, Remco Jonkers, Peter Ligthart, Masja de Haas, Lonneke Haer-Wigman,[...]. Br J Haematol 2016
21
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.